-
Light at the End of the Tunnel for ASPS Patients
Immunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
March 1: The Week in Cancer News
Many women must make decisions about preserving fertility while dealing with a cancer diagnosis, and head and neck cancer survivors face a higher stroke risk.
by Kevin McLaughlin
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
February 23: The Week in Cancer News
Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.
by Thomas Celona
-
Overcoming Lung Cancer Stigma With Understanding
Shirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
The More You Know About Cancer Prevention
Studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.
by Cancer Research Catalyst
-
February 16: The Week in Cancer News
Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.
by Kevin McLaughlin
-
Using Acupuncture and Massage to Manage Side Effects
New research finds acupuncture and massage are associated with pain reduction for patients with advanced cancer.
by Laura Gesualdi-Gilmore
-
February 9: The Week in Cancer News
Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.
by Marci A. Landsmann
-
February 2: The Week in Cancer News
Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.
by Eric Fitzsimmons
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona